IDBS
Scott Weiss, director, product strategy, IDBS.
Neural ID, the provider of the only collaborative biosignal analytics platform spanning the pharmaceutical lifecycle, teams up with IDBS for customer-focused collaboration. Launched during the recent Bio-IT World Conference & Expo in Boston, US, the collaborative offering delivers a fully integrated solution combining BioBook, IDBS’ ELN for life sciences, and Neural ID’s flagship product IWS, which provides users with automated data analysis and data reporting.
For the first time, BioBook users will have the ability to achieve full traceability and drill down capacity of the study lifecycle. This includes summary reports through study design and analysed data, down to processed instrumentation biosignals. The summary data reported into BioBook from IWS will be fully searchable, claimed to be a unique capability. Users of IWS will be able to generate deep analytic value across cardio safety assessments from discovery all the way through clinical applications and support GxP regulated environments.
“Researchers are keen to reduce study cycle times and accelerate decision making around the safety and efficacy of new products. We recognise the need for a consistent and reproducible way to automate waveform analysis throughout the drug discovery and development lifecycle,” said Scott Weiss, director, product strategy, IDBS. “Our collaboration with Neural ID addresses this critical need. The integration will eliminate manual data import, reducing transcription errors. It also provides improved user productivity with automated write-up and reporting.”
“The IDBS and Neural ID collaboration has already resulted in one top-20 pharmaceutical company integrating BioBook with IWS,” said Timothy Carruthers, CEO, Neural ID. “Customers are realising IWS expands their analysis capability to make better decisions, faster. We look forward to working with the IDBS team to help more of their customers accelerate bringing products to market.”
Neural ID, www.neuralid.com.
IDBS, www.idbs.com.